Article: Early Nicotinamide Riboside Supplementation Shows Promise in an Individual with Ataxia Telangiectasia: Case Report

Oct 12, 2022 Ataxia Telangiectasia Case Study Neurological Health

Early Nicotinamide Riboside Supplementation Shows Promise in an Individual with Ataxia Telangiectasia: Case Report

Objectives

To investigate the effects of NR supplementation in a 3.5-year-old male child with ataxia and recurrent bacterial infections. This was a case study of one individual.

Journal

Neuropediatrics

Key Outcomes

NR supplementation resulted in no adverse effects.
Neurological examination after 7 and 11 months of NR supplementation showed a clearer and more fluid speech and improvement in fine motor skills and movement disorder.
Use of antibiotics and frequency of hospitalizations due to infections were reduced by more than 90%.
The authors stated given the absence of adverse effects, they strongly encourage to consider NR supplementation in all individuals with ataxia telangiectasia.

Duration

11 months

Dose

25 mg/kg

Study Design

Clinical case study in 1 3.5-year-old child of Syrian parents

See Published Study

Healthy Aging & Longevity

Nicotinamide Riboside Delays Aging in DNA Repair-Deficient Mice: Preclinical Findings

Synopsis Even though cells can repair DNA, damage naturally builds up over time, harming cell function and contributing to aging. Finding ways to prevent DNA damage or improve repair could help ex...

Neurological Health

NAD+ Depletion Triggers SARM1 Activation and Cell Death, Prevented by PARP Inhibitors: Preclinical Findings

SynopsisSarm1 is a protein that drives programmed axon degeneration by breaking down NAD⁺, but its activity is controlled by NAD+ levels. This study found that in cells treated with the mitochondri...